Hogan Lovells Advises on Actavis' Acquisition of Silom Medical Company
03 April 2014
HONG KONG, 3 April 2014 – Hogan Lovells has advised leading global specialty pharmaceutical company Actavis plc ("Actavis") on its acquisition of Silom Medical Company Limited ("Silom Medical") for approximately US$100 million in cash.
Silom Medical is a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand. The acquisition of Silom Medical allows Dublin-headquartered Actavis to enhance its presence in the fast-growing Thai pharmaceutical market and create a foundation for Actavis' continued expansion across the Southeast Asian region.
Working with local counsel in Thailand, Hogan Lovells were able to provide the relevant cross-jurisdictional corporate and regulatory advice to help Actavis successfully complete the transaction.
This is the second deal in three months on which we have advised Actavis.
The Hogan Lovells team advising on the transaction was led by Hong Kong partner Tim Fletcher and consultant Charles Butcher, supported by senior associate Tamsin Doran and associate Valerie Fung.